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“Multiple Sclerosis (MS) is a chronic inflammatory disease of the central 
nervous system (CNS) characterized with focal plaques of demyelination and 
neurodegeneration in brain and spinal cord” (1). One of the surprising issues 
is facing with infant or young child who is suffering from MS. Biomarker is a 
biologic feature used to measure the presence or progress of disease or the effect 
of treatment. Many biomarkers can be used to diagnose MS such as body fluid 
biomarkers; Cerebrospinal fluid (CSF), plasma, tears, urine, and saliva have 
some biomarkers changing in MS (2). One of the unique body fluid presented in 
oral cavity is saliva and complex mixtures of secretory ingredients involved in 
formation of it. Considering the increasing prevalence of MS (both children and 
adults), the necessity of selecting the most efficient diagnostic and stage detecting 
tests becomes more and more clear. In this paper, we report many factors changed 
in saliva of MS patients.
Antibodies are proteins found in the serum, saliva, tears and many other body 
fluids as well as sites. Generally, they are produced in response to foreign antigens 
in the body. Immunoglobulin A (IgA) makes up the main immune barrier in 
response to foreign antigens in mucosal membranes. IgA is secreted in saliva 
mostly in polymeric form, associated with the role of the “joining segment”(3). 
The monomeric form of IgA can be detected in the saliva of patients with MS 
while it’s not routinely detected in healthy individuals (4).
Human leukocyte antigens (HLA) are protein molecules expressed on the surface 
of human leukocytes. HLA molecules are mostly bound to the cell surface but a 
very small amount of them also exists in the soluble form in serum, plasma and 
other body fluids (5). The average amount of soluble HLA class II (sHLA-II) in 
patients with MS showed increased levels of sHLA-II in the saliva of patients. 
sHLA-II elevations in the saliva were linked with increased CSF sHLA-II level 
which is now widely accepted as a means to evaluate disease activity in MS; 
hence salivary sHLA-II concentration might be a diagnostic tool used to indicate 
disease activity(6).
One of the therapeutic interventions available to patients with MS is interferon-
beta (IFN-beta) therapy (7); however, sHLA-II levels were measured in patients 
receiving IFN-beta therapy at 3-month intervals after the start of the therapy. 
Those results are indicative of increased sHLA-II levels in response to IFN-beta 
therapy with the mean value after 3 months being 821 units mL (6).
MiRNA (Micro Ribonucleic acid) molecules are small noncoding RNAs 
found to have regulatory and modulatory role in gene expression (8). Recently 
these molecules have been suggested as novel markers for inflammatory and 
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autoimmune diseases. Measuring MiRNA levels 
in body fluids might lend itself to a diagnostic tool 
for MS detection. Increased levels of MiRNA-17-
5p were found in peripheral blood CD4 (Cluster of 
Differentiation4) T-cells of MS patients. Decreased 
expression of MiRNA-20a and MiRNA-17 has been 
reported in patients with MS (9).
Oxidative stress (OS) is an imbalance in levels of pro-
oxidants and antioxidants; role of which in causing MS 
is proved. Saliva and plasma may contain markers of 
OS, which can reveal local and systemic diseases and 
may help in diagnosis, prognosis, and treatment of 
many diseases. Antioxidant enzymes like superoxide 
dismutase 1 and 2, catalase, and heme oxygenase 1 are 
remarkably higher in active demyelinating MS which 
is due to an adaptive defense against the OS (10, 11).
In conclusion, due to available methods of assessment 
of children, MS is invasive and stressful, survey of 
saliva compositional alterations is a non-invasive way 
for evaluation of disease progression, but the issue is 
open to discussion. 
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